Observations during an elective interruption of natalizumab treatment: A post-marketing study

Multiple Sclerosis Journal

Volumn 17, Issue 3, 2011, Pages 372-375

  Borriello, Giovanna ^a   Prosperini, Luca ^a   Marinelli, Fabiana ^a   Fubelli, Federica ^a   Pozzilli, Carlo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

magnetic resonance imaging; multiple sclerosis; natalizumab; observational study; progressive multifocal leukoencephalopathy; rebound

Indexed keywords

CORTICOSTEROID; NATALIZUMAB;

ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; DISEASE ACTIVITY; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROSPECTIVE STUDY; RECURRENT DISEASE;

EID: 79953208067     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510392098     Document Type: Article

References (10)

1. Tubridy N., Behan PO, Capildeo R., et al. The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. Neurology 1999 ; 53: 466-472. (Pubitemid 29382036)
2. Miller DH, Khan OA, Sheremata WA, et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2003 ; 348: 15-23. (Pubitemid 36026342)
3. O'Connor PW, Goodman A., Willmer-Hulme AJ, et al. Natalizumab Multiple Sclerosis Trial Group. Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects. Neurology 2004 ; 62: 2038-2043. (Pubitemid 38738218)
4. O'Connor PW, Goodman AD, Kappos L., et al. Return of disease activity after cessation of natalizumab therapy in patients with multiple sclerosis. Mult Scler 2009 ; 15: S240 - S241.
5. Vellinga MM, Castelijns JA, Barkhof F., Uitdehaag BM and Polman CH Post-withdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients. Neurology 2008 ; 70: 1150-1151. (Pubitemid 351464749)
6. Fox RJ and Kappos L. Is natalizumab overshooting its rebound? Neurology 2008 ; 70: 1073-1074. (Pubitemid 351464760)
7. Hartung HP New cases of progressive multi-focal leukoencephalopathy after treatment with natalizumab. Lancet Neurol 2009 ; 8: 28-31.
8. Schiess N. and Calabresi PA Natalizumab: bound to rebound ? Neurology 2009 ; 72: 392-393.
9. Kappos L., Bates D., Hartung HP, et al. Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. Lancet Neurol 2007 ; 6: 431-441. (Pubitemid 46551850)
10. Myhr KM and Mellgren SI Corticosteroids in the treatment of multiple sclerosis. Acta Neurol Scand 2009 ; 189 (Suppl): 73-80.